PUTNAM INVESTMENTS LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$72,323,978
-9.9%
772,362
-14.2%
0.11%
-6.8%
Q2 2023$80,310,006
+1.1%
899,832
+21.5%
0.12%
-7.1%
Q1 2023$79,435,224
-7.9%
740,862
+4.9%
0.13%
-15.9%
Q4 2022$86,273,731
+6.0%
706,409
-10.4%
0.15%
-2.6%
Q3 2022$81,376,000
+8.9%
788,065
-2.0%
0.16%
+15.7%
Q2 2022$74,732,000
+0.7%
803,911
+27.2%
0.13%
+19.6%
Q1 2022$74,192,000
+10.1%
632,169
+26.2%
0.11%
+16.7%
Q4 2021$67,415,000
-6.8%
501,115
+10.4%
0.10%
-14.3%
Q3 2021$72,357,000
+30.5%
453,961
+7.7%
0.11%
+30.2%
Q2 2021$55,445,000
+326.7%
421,473
+318.1%
0.09%
+290.9%
Q1 2021$12,993,000
-63.0%
100,816
-52.1%
0.02%
-64.5%
Q4 2020$35,137,000
-41.6%
210,679
-46.0%
0.06%
-47.5%
Q3 2020$60,198,000
-30.1%
390,087
-33.0%
0.12%
-35.5%
Q2 2020$86,079,000
+34.4%
582,008
+2.3%
0.18%
+8.9%
Q1 2020$64,060,000
+164.7%
568,871
+227.0%
0.17%
+236.0%
Q4 2019$24,199,000
+45.4%
173,947
+0.7%
0.05%
+35.1%
Q3 2019$16,644,000
-41.9%
172,796
-30.5%
0.04%
-42.2%
Q2 2019$28,640,000
+44.9%
248,716
+48.1%
0.06%
+39.1%
Q1 2019$19,763,000
+98.3%
167,911
+5.6%
0.05%
+76.9%
Q4 2018$9,965,000
-14.5%
159,056
-3.3%
0.03%
+4.0%
Q3 2018$11,653,000
+3420.5%
164,463
+774.4%
0.02%
+2400.0%
Q2 2015$331,000
+1.5%
18,8090.0%0.00%0.0%
Q1 2015$326,00018,8090.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
View complete list of ASCENDIS PHARMA A/S shareholders